NASDAQ:RKDA | Free Cash Flow | Arcadia Biosciences, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2014-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.1M
2025-12-31-$861,000.00$0.00-$861,000.00
2025-03-31-$1.59M$0.00-$1.59M-61.10%
2024-12-31-$2.21M$0.00-$2.21M
2024-03-31-$3.21M$13,000.00-$3.22M
2023-12-31-$4.15M$0.00-$4.15M
2023-03-31-$3.47M$0.00-$3.47M
2022-12-31-$2.36M$26,000.00-$2.38M
2022-03-31-$4.89M$40,000.00-$4.93M
2021-12-31-$6.66M$88,000.00-$6.75M
2021-03-31-$4.71M$485,000.00-$5.19M-252.28%
2020-12-31-$6.75M$297,000.00-$7.05M-79.21%
2020-03-31-$9.27M$778,000.00-$10.05M-397.94%
2019-12-31-$5.01M$599,000.00-$5.61M
2019-03-31-$3.97M$88,000.00-$4.06M
2018-12-31-$2.7M$161,000.00-$2.86M
2018-03-31-$2.62M$33,000.00-$2.65M
2017-12-31-$2.68M$2,000.00-$2.69M
2017-03-31-$4.53M$57,000.00-$4.59M
2016-12-31-$4.28M$9,000.00-$4.29M
2016-03-31-$4.86M$137,000.00-$4.99M
2015-12-31-$3.95M$71,000.00-$4.02M
2015-03-31-$2.6M$7,000.00-$2.61M
2014-12-31-$2.66M$108,000.00-$2.77M
2014-03-31-$2.13M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$4.74M$0.00-$4.74M
2024-12-31-$9.63M$16,000.00-$9.64M
2023-12-31-$15.29M$5,000.00-$15.3M
2022-12-31-$13.98M$72,000.00-$14.05M
2021-12-31-$25.87M$1.01M-$26.88M
2020-12-31-$30.22M$2.34M-$32.55M
2019-12-31-$17.2M$1.48M-$18.68M
2018-12-31-$13.63M$250,000.00-$13.88M
2017-12-31-$13.97M$79,000.00-$14.04M
2016-12-31-$17.06M$231,000.00-$17.29M
2015-12-31-$15.11M$151,000.00-$15.26M
2014-12-31-$14.79M$148,000.00-$14.94M